AS

Anurag Singh

Active Director Director DIN 06705116
DIN 06705116 First appointment Oct 2013 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2013
Shareholding value •••• Premium profile

About Anurag Singh

Data last updated:

Anurag Singh is a Director at Lifekind Pharmaceuticals Private Limited (since 2013). The company operates in Trading. Lifekind Pharmaceuticals Private Limited reported revenue of ₹25.9 Lakh (FY 2017).

DIN 06705116
Primary Designation Director
Industry Trading
First Appointment 01 Oct 2013
Oldest Company Age 15 yrs
Largest company Lifekind Pharmaceuticals Private Limited · ₹25.9 Lakh (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Oct 20132011₹25.9 Lakh (FY 2017)Active

Board colleagues of Anurag Singh

Directorship timeline

Open interactive timeline →
Lifekind Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anurag Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anurag Singh

Anurag Singh currently holds 1 directorship: Lifekind Pharmaceuticals Private Limited (Director, since 01 Oct 2013, revenue ₹25.9 Lakh (FY 2017)).

Anurag Singh was first appointed on 01 Oct 2013 as Director at Lifekind Pharmaceuticals Private Limited.

The current boards of Anurag Singh's companies include Amar Nath Choudhary (Lifekind Pharmaceuticals Private Limited), Babita Rao (Lifekind Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available